OGG1 and type 2 diabetes mellitus: Overexpression of hOGG1 in the mitochondria can reduce FFA-induced inhibition of ATP production and reduce apoptosis of islet β cells, suggesting that OGG1 may be a new target for intervention in type 2 diabetes mellitus [119].